Dottikon ES Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Dottikon ES Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Dottikon ES Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Dottikon ES Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for the chemical and pharmaceutical industries. The company finds novel uses for hazardous reactions and continuous processing that facilitate the reduction of chemical synthesis routes, increase output and minimize waste. Dottikon uses its technology to design, develop and optimize chemical processes, and increase production from kilograms to tons. It also offers high-purity isosorbide dimethyl ether, which finds application in cosmetics, pharmaceutical, chemical and agricultural industries. The company also provides recycling and waste management services including recycling of solvents and purification and wastewater treatment. It operates through Dottikon ES Group with a presence in North America, Europe and Asia-Pacific. Dottikon is headquartered in Dottikon, Aargau, Switzerland
Headquarters
Switzerland
Address
Hembrunnstrasse 17, Dottikon, Aargau, 5605
Website
www.dottikon.com
Telephone
41 566 168111
No of Employees
860
Industry
Chemicals
Ticker Symbol & Exchange
DESN (SWF)
Revenue (2025)
$437.6M
18.1%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
30.9%
(2025 vs 2024)
Market Cap*
$4.8B
Net Profit Margin (2025)
XYZ
10.9%
(2025 vs 2024)
* As of and is in US$
Dottikon ES Holding AG premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Amines | Recycling and Waste Treatment | Dottisol |
| Anilines | Contract Manufacturing | |
| Azaindoles | Project Management | |
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | Dottikon ES Holding AG | Novartis AG | Lonza Group Ltd | Siegfried Holding AG | Bachem Holding AG |
|---|---|---|---|---|---|
| Headquarters | Switzerland | Switzerland | Switzerland | Switzerland | Switzerland |
| City | Dottikon | Basel | Basel | Zofingen | Bubendorf |
| State/Province | Aargau | Basel-Stadt | - | Aargau | - |
| No. of Employees | 860 | 75,883 | 19,771 | 3,926 | 2,292 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Markus Blocher | Chief Executive Officer; Chairman | Executive Board | 2012 | 55 |
| Pierre-Alain Ruffieux | Deputy Chairman | Executive Board | 2024 | 57 |
| Marlene Born | Chief Financial Officer | Senior Management | 2006 | 51 |
| Stephan Kirschbaum | Head - Business Development | Senior Management | 2009 | 59 |
| Thomas Rosatzin | Head - Purchasing | Senior Management | 2014 | 64 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer